Veselinović, Tanja http://orcid.org/0000-0001-7906-6966
Vernaleken, Ingo
Janouschek, Hildegard
Cumming, Paul
Paulzen, Michael
Mottaghy, Felix M.
Gründer, Gerhard
Article History
Received: 10 August 2017
Accepted: 18 April 2018
First Online: 1 May 2018
Compliance with ethical standards
:
: Dr. Vernaleken has served on the speakers’ bureau of Bristol-Myers Squibb (New York, NY), Eli Lilly (Indianapolis, Ind), and GlaxoSmithKline (London, UK). Dr. Gründer has served as a consultant for Allergan (Dublin, Ireland), Boehringer Ingelheim (Ingelheim, Germany), Eli Lilly (Indianapolis, Ind, USA), Janssen-Cilag (Neuss, Germany), Lundbeck (Copenhagen, Denmark), Ono Pharmaceuticals (Osaka, Japan), Otsuka (Chiyoda, Japan), Recordati (Milan, Italy), Roche (Basel, Switzerland), Servier (Paris, France), and Takeda (Osaka, Japan). He has served on the speakers’ bureau of Eli Lilly, Janssen Cilag, Neuraxpharm (Langenfeld, Germany), Roche, Servier, and Trommsdorf (Aachen, Germany). He has received grant support from Boehringer Ingelheim and Roche. He is co-founder of Mind and Brain Institute GmbH (Zornheim, Germany) and Brainfoods GmbH (Zornheim, Germany). Dr. Veselinović, Dr. Janouschek, Prof. Cumming, Dr. Paulzen, and Dr. Mottaghy declare no conflicts of interest.